NDC 81660-111

TADINOSE

Loratadina

TADINOSE is a Oral Capsule in the Human Otc Drug category. It is labeled and distributed by Grimann, S.a. De C.v.. The primary component is Loratadine.

Product ID81660-111_bc7ca2d2-0814-199e-e053-2a95a90a811a
NDC81660-111
Product TypeHuman Otc Drug
Proprietary NameTADINOSE
Generic NameLoratadina
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2021-05-05
Marketing CategoryNDA /
Application NumberNDA216100
Labeler NameGrimann, S.A. de C.V.
Substance NameLORATADINE
Active Ingredient Strength10 mg/U
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 81660-111-01

10 U in 1 BLISTER PACK (81660-111-01)
Marketing Start Date2021-05-05
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.